Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chronic Myeloid Leukemia

Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia

Bone Marrow Transplantation volume 32, pages 1065–1069 (2003)Cite this article

Summary:

Increased bone marrow angiogenesis is a poor prognostic marker in patients with chronic myelogenous leukemia (CML). Allogeneic stem cell transplantation (ASCT) can be curative for patients with CML. Studies in myeloma have shown persistent increased bone marrow microvessel density (MVD) after autologous transplantation. It is not clear if abnormal bone marrow angiogenesis persists following a curative intervention like allogeneic transplantation. We evaluated MVD from bone marrow samples obtained just prior to and at 3–5 months after ASCT in 24 patients with CML. The median MVD pre-transplant was 14 (4–37), with 11 patients having high-grade angiogenesis and 13 having low grade. The median post transplant MVD was 20 (range 5–36), with 12 patients having high-grade angiogenesis and 12 low grade. The median time between biopsies was 4 months (range 1–6 months). The microvessels in the post transplant bone marrow appeared morphologically different with striking dilatation and sinusoidal appearance compared to the pre-transplant marrow. However, there was no significant change in MVD following transplant (P=0.8, paired t-test). Abnormal bone marrow angiogenesis appears to persist in the bone marrow following ASCT for CML, at least in the short term.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Folkman J . Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis [see comments]. N Engl J Med 1995; 333: 1757–1763.

    Article  CAS  PubMed  Google Scholar 

  2. Folkman J . New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32A: 2534–2539.

    Article  CAS  PubMed  Google Scholar 

  3. Li VW, Folkerth RD, Watanabe H et al. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 1994; 344: 82–86.

    Article  CAS  PubMed  Google Scholar 

  4. Maeda K, Chung YS, Ogawa Y et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77: 858–863.

    Article  CAS  PubMed  Google Scholar 

  5. Vermeulen PB, Verhoeven D, Fierens H et al. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 1995; 71: 340–343.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gasparini G, Barbareschi M, Boracchi P et al. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1995; 1: 131.

    CAS  PubMed  Google Scholar 

  7. Hussong JW, Rodgers GM, Shami PJ . Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309–313.

    CAS  PubMed  Google Scholar 

  8. Kini AR, Kay NE, Peterson LC . Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414–1418.

    Article  CAS  PubMed  Google Scholar 

  9. Padro T, Ruiz S, Bieker R et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637–2644.

    CAS  PubMed  Google Scholar 

  10. Schneider P, Jerome MV, Paysant J et al. The role of angiogenesis in leukemia proliferation. Am J Pathol 1999; 155: 1007–1008.

    CAS  PubMed  Google Scholar 

  11. Perez-Atayde AR, Sallan SE, Tedrow U et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815–821.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Aguayo A, Kantarjian H, Manshouri T et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245.

    CAS  PubMed  Google Scholar 

  13. Di Raimondo F, Palumbo GA, Molica S, Giustolisi R . Angiogenesis in chronic myeloproliferative diseases. Acta Haematol 2001; 106: 177–183.

    Article  CAS  PubMed  Google Scholar 

  14. Korkolopoulou P, Viniou N, Kavantzas N et al. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia 2003; 17: 89–97.

    Article  CAS  PubMed  Google Scholar 

  15. Lundberg LG, Lerner R, Sundelin P et al. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000; 157: 15–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Rajkumar SV, Leong T, Roche PC et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000; 6: 3111–3116.

    CAS  PubMed  Google Scholar 

  17. Rajkumar SV, Greipp PR . Prognostic factors in multiple myeloma. Hematol Oncol Clin N Am 1999; 13: 1295–1314, xi.

    Article  CAS  Google Scholar 

  18. Vacca A, Ribatti D, Roncali L et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503–508.

    Article  CAS  PubMed  Google Scholar 

  19. Mesa RA, Hanson CA, Rajkumar SV et al. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 2000; 96: 3374–3380.

    CAS  PubMed  Google Scholar 

  20. Vermeulen PB, Gasparini G, Fox SB et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32A: 2474–2484.

    Article  CAS  PubMed  Google Scholar 

  21. Bostwick DG, Wheeler TM, Blute M et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996; 48: 47–57.

    Article  CAS  PubMed  Google Scholar 

  22. Vacca A, Ribatti D, Roncali L, Dammacco F . Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 1995; 20: 27–38.

    Article  CAS  PubMed  Google Scholar 

  23. Rajkumar SV, Fonseca R, Witzig TE et al. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia 1999; 13: 469–472.

    Article  CAS  PubMed  Google Scholar 

  24. Fox SB, Leek RD, Weekes MP et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995; 177: 275–283.

    Article  CAS  PubMed  Google Scholar 

  25. Ebos JM, Tran J, Master Z et al. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. Mol Cancer Res 2002; 1: 89–95.

    CAS  PubMed  Google Scholar 

  26. Kumar S, Fonseca R, Dispenzieri A et al. Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br J Haematol 2002; 119: 665–671.

    Article  CAS  PubMed  Google Scholar 

  27. Weidner N, Semple JP, Welch WR, Folkman J . Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8.

    Article  CAS  PubMed  Google Scholar 

  28. Folkman J, Shing Y . Angiogenesis. J Biol Chem 1992; 267: 10931–10934.

    CAS  PubMed  Google Scholar 

  29. Bussolino F, Mantovani A, Persico G . Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997; 22: 251–256.

    Article  CAS  PubMed  Google Scholar 

  30. Bussolino F, Albini A, Camussi G et al. Role of soluble mediators in angiogenesis. Eur J Cancer 1996; 32A: 2401–2412.

    Article  CAS  PubMed  Google Scholar 

  31. Ellis LM, Fidler IJ . Angiogenesis and metastasis. Eur J Cancer 1996; 32A: 2451–2460.

    Article  CAS  PubMed  Google Scholar 

  32. Rajkumar SV, Mesa RA, Fonseca R et al. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 2002; 8: 2210–2216.

    PubMed  Google Scholar 

  33. Fiedler W, Graeven U, Ergun S et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–1875.

    CAS  PubMed  Google Scholar 

  34. Verstovsek S, Kantarjian H, Manshouri T et al. Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer 2002; 94: 1517–1521.

    Article  CAS  PubMed  Google Scholar 

  35. Gunsilius E, Duba HC, Petzer AL et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000; 355: 1688–1691.

    Article  CAS  PubMed  Google Scholar 

  36. Mayerhofer M, Valent P, Sperr WR et al. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. Blood 2002; 100: 3767–3775.

    Article  CAS  PubMed  Google Scholar 

  37. Janowska-Wieczorek A, Majka M, Marquez-Curtis L et al. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 2002; 16: 1160–1166.

    Article  CAS  PubMed  Google Scholar 

  38. Folkman J . Angiogenesis-dependent diseases. Semin Oncol 2001; 28: 536–542.

    Article  CAS  PubMed  Google Scholar 

  39. Hlatky L, Hahnfeldt P, Folkman J . Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94: 883–893.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

    S Kumar, M R Litzow & S V Rajkumar

Authors
  1. S Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M R Litzow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S V Rajkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S V Rajkumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, S., Litzow, M. & Rajkumar, S. Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia. Bone Marrow Transplant 32, 1065–1069 (2003). https://doi.org/10.1038/sj.bmt.1704260

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704260

Keywords

Search

Advanced search

Quick links